Reyhan Dedeoglu

Prof. Dr. Reyhan Dedeoglu

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2021 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
FHFatih Haslak
Fatih Haslak
KBKenan Barut
Kenan Barut
CDCANSU DURAK
CANSU DURAK
AAAyten Aliyeva
Ayten Aliyeva
MYMehmet Yildiz
Mehmet Yildiz
OKOzgur Kasapcopur
Ozgur Kasapcopur

10 April 2015 in Turkish Archives of Pediatrics
Verified
Journal Article
Closed access
SASezen UGAN ATİK
Sezen UGAN ATİK
RDReyhan Dedeoglu
Reyhan Dedeoglu
FVFatih Varol
Fatih Varol
HCHalit Cam
Halit Cam
AEAyse Guler Eroglu
Ayse Guler Eroglu
LSLevent Saltik
Levent Saltik
Information about the effects of synthetic cannabinoids "bonzai" on the cardiovascular system is limited. In this article, two patients in whom different cardiological side effects were observed following use of synthetic cannabinoids 'bonzai' were presented. Our first patient who was a 16-year old boy presented to pediatric emergency department with severe chest pain which had started one hour before. On electrocardiographic examination, ST segment elevations greater than 3 mm were observed in DII, DIII, AVF and V5-V6 derivations which caused to suspicious myocardial infarction. Cardiac catheterization was performed and coronary angiographic findings were found to be normal. When the patient was questioned again, it was learned that he used synthetic cannabinoid 'bonzai'. The second patient who was aged 18 years and addicted to synthetic cannabinoid 'bonzai' was brought to our emergency department by his friends because of clouding of consciousness. Dopamine treatment was started in the patient whose cardiac apical beat reduced to 40/min and who was found to develop hypertension, because bradycardia worsened. However, the blood pressure increased rapidly and dopamine treatment was stopped. Heart rate and blood pressure monitoring was continued. Use of synthetic cannabinoids 'bonzai' should be kept in mind in patients who present to emergency departments with chest pain and complaints related with the cardiovascular system.

5 April 2017 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
RDReyhan Dedeoglu
Reyhan Dedeoglu
KBKenan Barut
Kenan Barut
FOFunda Oztunc
Funda Oztunc
SASezen Atik
Sezen Atik
AAAmra Adrovic
Amra Adrovic
OKOzgur Kasapcopur
Ozgur Kasapcopur
Speckle-tracking echocardiography is a recently developed technique for the evaluation of myocardial deformation or strain. Our objective was to examine strain through a mid-term follow-up of patients with Kawasaki disease.Methods: We explored left ventricular mechanics using speckle-tracking echocardiography in 35 patients with a history of Kawasaki disease at least 6 months after the acute phase. We also included 30 healthy children as controls. Strain data sets were acquired for the quantification of left ventricular global strain, segmental strain, and left ventricular ejection fraction.Results: The mean age of our patients was 25.6±15.4 months. At a median follow-up of 57.5 months (16.5–98.2), although both values were in the normal range, the mean left ventricular ejection proportion of patients (57.3%) was a little lower than that of controls (p⩽0.05). Patient strain values at the basal inferoseptal (20.0), basal anterolateral (19.5), apical septal (23.3), and apical inferior (24.0) segments were lower compared with controls. In all, seven patients had coronary aneurysms during follow-up. Kawasaki disease patients with pyuria had lower left ventricular strain at the mid anterior, mid anteroseptal, apical anterior, and apical inferior segments and global longitudinal strain compared with patients with no pyuria (p⩽0.05).Conclusion: In children with a history of Kawasaki disease, impairment of left ventricular mechanics occurs especially within the left anterior descending artery territories.

21 February 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
HBHelen Aghdasi Bornaun
Helen Aghdasi Bornaun
NYNuh Yılmaz
Nuh Yılmaz
GKGünsel Kutluk
Günsel Kutluk
RDReyhan Dedeoglu
Reyhan Dedeoglu
KÖKazım Öztarhan
Kazım Öztarhan
FŞFatih Şap
Fatih Şap
Objectives.Ulcerative colitis (UC) and Crohn’s disease (CD) are chronic inflammatory bowel diseases (IBD) with unclear underlying aetiologies. Severe cardiac arrhythmias have been emphasised in a few studies on adult IBD patients. This study aimed to investigate the alteration of the P-wave and QT interval dispersion parameters to assess the risk of atrial conduction and ventricular repolarisation abnormalities in pediatric IBD patients.Patients and Methods.Thirty-six IBD patients in remission (UC: 20, CD: 16) aged 3–18 years and 36 age- and sex-matched control patients were enrolled in the study. Twelve-lead electrocardiograms were used to determine durations of P-wave, QT, and corrected QT (QTc) interval dispersion. Transthoracic echocardiograms and 24-hour rhythm Holter recordings were obtained for both groups.Results.The P-wave dispersion, QT dispersion, and QTc interval dispersion (Pdisp, QTdisp, and QTcdisp) were significantly longer in the patient group. The mean values of Pminimum, Pmaximum, and QTcminimum were significantly different between the two groups. The echocardiography and Holter monitoring results were not significantly different between the groups. Furthermore, no differences in these parameters were detected between the CD and UC groups.Conclusion.Results suggest that paediatric IBD patients may carry potential risks for serious atrial and ventricular arrhythmias over time even during remission.

3 May 2016 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
RDReyhan Dedeoglu
Reyhan Dedeoglu
SŞSezgin Şahin
Sezgin Şahin
AKAida Koka
Aida Koka
FÖFunda Öztunç
Funda Öztunç
AAAmra Adroviç
Amra Adroviç
OKOzgur Kasapcopur
Ozgur Kasapcopur

25 August 2023 in Turkish Archives of Pediatrics
Verified
Journal Article
Open access
DADilek Uludağ Alkaya
Dilek Uludağ Alkaya
B1Birol Öztürk 1
Birol Öztürk 1
AÜAylin Yüksel Ülker
Aylin Yüksel Ülker
SBSerdar Bozlak
Serdar Bozlak
EÖEsra Öztürk
Esra Öztürk
BTBeyhan Tüysüz
Beyhan Tüysüz
Objective: Congenital heart defects occur in approximately 50% of children with Down syndrome and they contribute considerably to morbidity and mortality. The aim of this study is to investigate the prevalence, classification, and survival of congenital heart defects in Down syndrome. Materials and Methods: About 1731 Down syndrome patients who underwent echocardiography between 1986 and 2022 were evaluated. The median follow-up duration was 8.7 years (range 1-35.8 years). Congenital heart defect was grouped as cyanotic and acyanotic. Results: Among the 1731 patients, 52.1% had congenital heart defects. Congenital heart defect was significantly more common in females than males. The most common cardiac defect was ventricular septal defect (35%), followed by atrial septal defect (31.8%), atrioventricular septal defect (23.4%), tetralogy of Fallot (5%), and patent ductus arteriosus (3.6%). In the follow-up, 43.2% of atrial septal defect, 17.8% of ventricular septal defect, and a total of 20% of congenital heart defects were closed spontaneously. About 34.4% of congenital heart defect was corrected by cardiac surgery/intervention. Five-year survival rate was 97.4% in patients without congenital heart defects, whereas it was 95.6% in mild congenital heart defects and 86.1% in moderate to severe congenital heart defects. There was no relationship between consanguinity, parental age, maternal disease, folic acid supplementation before/during pregnancy, gestational age, birth weight, and congenital heart defects. Neuromotor development was similar in patients with and without congenital heart defects. Conclusion: We demonstrated that almost half of the patients had congenital heart defects; ventricular septal defect was the most common congenital heart defect type. This study is valuable in terms of the largest single-center study describing the classification, prognostic factors, and survival of Down syndrome patients with congenital heart defect from Turkey. Cite this article as: Uludağ Alkaya D, Öztürk B, Yüksel Ülker A, et al. Congenital heart defects and outcome in a large cohort of Down syndrome: A single-center experience from Turkey. Turk Arch Pediatr. 2023;58(5):473-479.